Sulfadicramide

DB13214

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 254.3
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

113 Data
Nicotine The risk or severity of adverse effects can be increased when Sulfadicramide is combined with Nicotine.
Mecamylamine The risk or severity of adverse effects can be increased when Sulfadicramide is combined with Mecamylamine.
Pentolinium The risk or severity of adverse effects can be increased when Sulfadicramide is combined with Pentolinium.
Trimethaphan The risk or severity of adverse effects can be increased when Sulfadicramide is combined with Trimethaphan.
Hexamethonium The risk or severity of adverse effects can be increased when Sulfadicramide is combined with Hexamethonium.
Cyclopentamine The risk or severity of adverse effects can be increased when Sulfadicramide is combined with Cyclopentamine.
Methotrexate The protein binding of Methotrexate can be increased when combined with Sulfadicramide.
Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfadicramide.
Dexketoprofen The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Sulfadicramide.
Cyclosporine The risk or severity of renal failure can be increased when Sulfadicramide is combined with Cyclosporine.
Insulin human The risk or severity of hypoglycemia can be increased when Sulfadicramide is combined with Insulin human.
Insulin lispro The risk or severity of hypoglycemia can be increased when Sulfadicramide is combined with Insulin lispro.
Insulin glargine The risk or severity of hypoglycemia can be increased when Sulfadicramide is combined with Insulin glargine.
Insulin pork The risk or severity of hypoglycemia can be increased when Sulfadicramide is combined with Insulin pork.
Troglitazone The therapeutic efficacy of Troglitazone can be increased when used in combination with Sulfadicramide.
Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Sulfadicramide.
Sulfisoxazole The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Sulfadicramide.
Disopyramide The therapeutic efficacy of Disopyramide can be increased when used in combination with Sulfadicramide.
Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Sulfadicramide.
Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Sulfadicramide.
Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Sulfadicramide.
Rosiglitazone The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Sulfadicramide.
Acetohexamide The therapeutic efficacy of Acetohexamide can be increased when used in combination with Sulfadicramide.
Quinine The therapeutic efficacy of Quinine can be increased when used in combination with Sulfadicramide.
Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Sulfadicramide.
Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Sulfadicramide.
Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Sulfadicramide.
Pentamidine The therapeutic efficacy of Pentamidine can be increased when used in combination with Sulfadicramide.
Mifepristone The therapeutic efficacy of Mifepristone can be increased when used in combination with Sulfadicramide.
Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Sulfadicramide.
Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Sulfadicramide.
Phenformin The therapeutic efficacy of Phenformin can be increased when used in combination with Sulfadicramide.
Sulfamethoxazole The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Sulfadicramide.
Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Sulfadicramide.
Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Sulfadicramide.
Gliclazide The therapeutic efficacy of Gliclazide can be increased when used in combination with Sulfadicramide.
Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Sulfadicramide.
Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Sulfadicramide.
Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Sulfadicramide.
Gliquidone The therapeutic efficacy of Gliquidone can be increased when used in combination with Sulfadicramide.
Mitiglinide The therapeutic efficacy of Mitiglinide can be increased when used in combination with Sulfadicramide.
Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Sulfadicramide.
Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Sulfadicramide.
Exenatide The therapeutic efficacy of Exenatide can be increased when used in combination with Sulfadicramide.
Mecasermin The therapeutic efficacy of Mecasermin can be increased when used in combination with Sulfadicramide.
Pramlintide The therapeutic efficacy of Pramlintide can be increased when used in combination with Sulfadicramide.
Glisoxepide The therapeutic efficacy of Glisoxepide can be increased when used in combination with Sulfadicramide.
Insulin aspart The risk or severity of hypoglycemia can be increased when Sulfadicramide is combined with Insulin aspart.
Insulin detemir The risk or severity of hypoglycemia can be increased when Sulfadicramide is combined with Insulin detemir.
Insulin glulisine The risk or severity of hypoglycemia can be increased when Sulfadicramide is combined with Insulin glulisine.
Glymidine The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfadicramide.
AICA ribonucleotide The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Sulfadicramide.
Buformin The therapeutic efficacy of Buformin can be increased when used in combination with Sulfadicramide.
Vildagliptin The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfadicramide.
Voglibose The therapeutic efficacy of Voglibose can be increased when used in combination with Sulfadicramide.
NN344 The risk or severity of hypoglycemia can be increased when Sulfadicramide is combined with NN344.
AMG-222 The therapeutic efficacy of AMG-222 can be increased when used in combination with Sulfadicramide.
Bisegliptin The therapeutic efficacy of Bisegliptin can be increased when used in combination with Sulfadicramide.
Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Sulfadicramide.
Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Sulfadicramide.
Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Sulfadicramide.
Liraglutide The therapeutic efficacy of Liraglutide can be increased when used in combination with Sulfadicramide.
Gosogliptin The therapeutic efficacy of Gosogliptin can be increased when used in combination with Sulfadicramide.
Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Sulfadicramide.
Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfadicramide.
Glibornuride The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfadicramide.
Benfluorex The therapeutic efficacy of Benfluorex can be increased when used in combination with Sulfadicramide.
Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Sulfadicramide.
Albiglutide The therapeutic efficacy of Albiglutide can be increased when used in combination with Sulfadicramide.
Dulaglutide The therapeutic efficacy of Dulaglutide can be increased when used in combination with Sulfadicramide.
Lobeglitazone The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Sulfadicramide.
Netoglitazone The therapeutic efficacy of Netoglitazone can be increased when used in combination with Sulfadicramide.
Rivoglitazone The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Sulfadicramide.
Ciglitazone The therapeutic efficacy of Ciglitazone can be increased when used in combination with Sulfadicramide.
Lixisenatide The therapeutic efficacy of Lixisenatide can be increased when used in combination with Sulfadicramide.
Insulin beef The risk or severity of hypoglycemia can be increased when Sulfadicramide is combined with Insulin beef.
Insulin degludec The risk or severity of hypoglycemia can be increased when Sulfadicramide is combined with Insulin degludec.
Insulin peglispro The risk or severity of hypoglycemia can be increased when Sulfadicramide is combined with Insulin peglispro.
Insulin tregopil The risk or severity of hypoglycemia can be increased when Sulfadicramide is combined with Insulin tregopil.
Ipragliflozin The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Sulfadicramide.
Dutogliptin The therapeutic efficacy of Dutogliptin can be increased when used in combination with Sulfadicramide.
Allicin The therapeutic efficacy of Allicin can be increased when used in combination with Sulfadicramide.
Tofogliflozin The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Sulfadicramide.
Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Sulfadicramide.
2,4-thiazolidinedione The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Sulfadicramide.
Teneligliptin The therapeutic efficacy of Teneligliptin can be increased when used in combination with Sulfadicramide.
Omarigliptin The therapeutic efficacy of Omarigliptin can be increased when used in combination with Sulfadicramide.
Carmegliptin The therapeutic efficacy of Carmegliptin can be increased when used in combination with Sulfadicramide.
Gemigliptin The therapeutic efficacy of Gemigliptin can be increased when used in combination with Sulfadicramide.
Anagliptin The therapeutic efficacy of Anagliptin can be increased when used in combination with Sulfadicramide.
Evogliptin The therapeutic efficacy of Evogliptin can be increased when used in combination with Sulfadicramide.
Sotagliflozin The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Sulfadicramide.
Balaglitazone The therapeutic efficacy of Balaglitazone can be increased when used in combination with Sulfadicramide.
Remogliflozin etabonate The therapeutic efficacy of Remogliflozin etabonate can be increased when used in combination with Sulfadicramide.
Carbutamide The therapeutic efficacy of Carbutamide can be increased when used in combination with Sulfadicramide.
Guar gum The therapeutic efficacy of Guar gum can be increased when used in combination with Sulfadicramide.
Metahexamide The therapeutic efficacy of Metahexamide can be increased when used in combination with Sulfadicramide.
Semaglutide The therapeutic efficacy of Semaglutide can be increased when used in combination with Sulfadicramide.
Taspoglutide The therapeutic efficacy of Taspoglutide can be increased when used in combination with Sulfadicramide.
Englitazone The therapeutic efficacy of Englitazone can be increased when used in combination with Sulfadicramide.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul